AU773038B2 - Aminosterol compounds and uses thereof - Google Patents

Aminosterol compounds and uses thereof Download PDF

Info

Publication number
AU773038B2
AU773038B2 AU55575/99A AU5557599A AU773038B2 AU 773038 B2 AU773038 B2 AU 773038B2 AU 55575/99 A AU55575/99 A AU 55575/99A AU 5557599 A AU5557599 A AU 5557599A AU 773038 B2 AU773038 B2 AU 773038B2
Authority
AU
Australia
Prior art keywords
compound
aminosterol
acceptable salt
following structure
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU55575/99A
Other languages
English (en)
Other versions
AU5557599A (en
Inventor
Binyamin Feibush
William Kinney
Lincoln Noecker
Meena Rao
Michael Zasloff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genaera Corp
Original Assignee
Genaera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaera Corp filed Critical Genaera Corp
Publication of AU5557599A publication Critical patent/AU5557599A/en
Assigned to GENAERA CORPORATION reassignment GENAERA CORPORATION Amend patent request/document other than specification (104) Assignors: MAGAININ PHARMACEUTICALS, INC.
Application granted granted Critical
Publication of AU773038B2 publication Critical patent/AU773038B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU55575/99A 1998-08-12 1999-08-12 Aminosterol compounds and uses thereof Ceased AU773038B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9633798P 1998-08-12 1998-08-12
US60/096337 1998-08-12
PCT/US1999/018322 WO2000009137A2 (en) 1998-08-12 1999-08-12 Aminosterol compounds and uses thereof

Publications (2)

Publication Number Publication Date
AU5557599A AU5557599A (en) 2000-03-06
AU773038B2 true AU773038B2 (en) 2004-05-13

Family

ID=22256894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55575/99A Ceased AU773038B2 (en) 1998-08-12 1999-08-12 Aminosterol compounds and uses thereof

Country Status (8)

Country Link
US (1) US6388108B1 (enExample)
EP (1) EP1105407B1 (enExample)
JP (1) JP2002522501A (enExample)
AT (1) ATE375359T1 (enExample)
AU (1) AU773038B2 (enExample)
CA (1) CA2339174C (enExample)
DE (1) DE69937301T2 (enExample)
WO (1) WO2000009137A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
IL157578A0 (en) * 2001-03-21 2004-03-28 Leo Pharma As Novel fusidic derivatives
KR20040097287A (ko) * 2002-04-05 2004-11-17 레오 파마 에이/에스 분지된 폴리아민 스테로이드 유도체
US20070129690A1 (en) 2005-12-02 2007-06-07 Joel Rosenblatt Catheter with polymeric coating
WO2008038965A1 (en) * 2006-09-26 2008-04-03 Kyungpook National University Industry-Academic Cooperation Foundation 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient
AU2007327761A1 (en) * 2006-12-08 2008-06-12 Jado Technologies Gmbh Cholesterylamines for the treatment and prevention of infectious diseases
US20080188830A1 (en) * 2007-02-06 2008-08-07 Arrow International, Inc. Selectively reinforced medical devices
CA2985271A1 (en) * 2007-09-06 2009-03-12 Ohr Pharmaceutical, Inc. A method for treating diabetes
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
WO2009090063A1 (en) * 2008-01-16 2009-07-23 Jado Technologies Gmbh Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
US20100082097A1 (en) * 2008-10-01 2010-04-01 Joel Rosenblatt Article Containing Segregated Biguanide and Lewis Acid
WO2011056650A2 (en) 2009-10-27 2011-05-12 Michael Zasloff Methods and compositions for treating and preventing viral infections
WO2011066260A2 (en) * 2009-11-25 2011-06-03 Michael Zasloff Formulations comprising aminosterols
US10040817B2 (en) 2013-10-03 2018-08-07 Enterin Laboratories, Inc. Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
MX356006B (es) * 2013-10-18 2018-04-24 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos.
CA3037712A1 (en) * 2016-09-21 2018-03-29 Mount Desert Island Biological Laboratory Methods and compositions for stimulation and enhancement of regeneration of tissues
EP3678671A4 (en) 2017-09-08 2022-12-07 Enterin, Inc. METHODS OF TREATMENT OF SLEEPING DISEASES, SLEEP DISORDERS AND RELATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721226A (en) * 1993-03-10 1998-02-24 Magainin Pharmaceuticals Inc. Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives
US5737691A (en) * 1995-07-14 1998-04-07 Motorola, Inc. System and method for allocating frequency channels in a two-way messaging network

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192756A (en) * 1992-03-18 1993-03-09 The Children's Hospital Of Pennsylvania Aminosterol antibiotic
US5840936A (en) 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US5763430A (en) 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
PT910382E (pt) * 1996-04-26 2003-10-31 Genaera Corp Esqualamina em combinacao com outros agentes anti-cancro para o tratamento de tumores
US6262283B1 (en) * 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721226A (en) * 1993-03-10 1998-02-24 Magainin Pharmaceuticals Inc. Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives
US5733899A (en) * 1993-03-10 1998-03-31 Magainin Pharmaceuticals Inc. Method for treating infection using steroid based pharmaceutical compositions
US5737691A (en) * 1995-07-14 1998-04-07 Motorola, Inc. System and method for allocating frequency channels in a two-way messaging network

Also Published As

Publication number Publication date
ATE375359T1 (de) 2007-10-15
DE69937301T2 (de) 2008-08-14
EP1105407B1 (en) 2007-10-10
EP1105407A2 (en) 2001-06-13
US6388108B1 (en) 2002-05-14
DE69937301D1 (de) 2007-11-22
CA2339174C (en) 2009-01-06
EP1105407A4 (en) 2004-03-17
CA2339174A1 (en) 2000-02-24
WO2000009137A2 (en) 2000-02-24
JP2002522501A (ja) 2002-07-23
WO2000009137A3 (en) 2000-05-18
AU5557599A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
Moore et al. Squalamine: an aminosterol antibiotic from the shark.
CA2339174C (en) Aminosterol compounds and uses thereof
JP3286321B2 (ja) 新規なアミノステロール抗生物質
US5583239A (en) Antimicrobial sterol conjugates
EP0014815A2 (de) Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
DE3100974A1 (de) Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
JP2009102446A (ja) 抗菌活性を有する半合成グリコペプチド
DE3888357T2 (de) Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
WO2007038868A2 (en) Novel enediyne compound and uses thereof
WO2010032269A2 (en) Anti-inflammatory activity of the iridoid glycosides
US9090655B2 (en) Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
DE68921128T2 (de) Pipocolinsäure enthaltende cyclische Peptolide, ihre Herstellung und sie enthaltende Zusammensetzungen.
EP0792886A1 (en) Novel peptide and therapeutic agent
Diaz et al. Studies on the relationship of structure to antimicrobial properties of diterpenoid compounds from Sideritis
US5834453A (en) Methods for the manufacture and use of antimicrobial sterol conjugates
JP4195089B2 (ja) 亜酸化物単位から製造される巨大環式化合物
AT402822B (de) Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3887292T2 (de) Antibiotische Verbindungen, genannt A/16686-Faktoren A'1,A'2 und A'3.
EP1572226B1 (de) Peptide mit hohem cysteingehalt
TWI923787B (zh) 一種阿尼芬淨衍生物的製備方法及其中間體
CN120699105B (zh) 一种氘代抗菌肽及其组合物和应用
EP0307553A2 (de) Modifizierte Splenopentine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69116383T2 (de) Hexapeptidderivate von teicoplanin und verfahren zu deren herstellung
WO1986001716A2 (fr) Utilisation des derives de la pyrrothine
JP3135491B2 (ja) 新規抗生物質

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: GENAERA CORPORATION

Free format text: FORMER NAME: MAGAININ PHARMACEUTICALS, INC.

FGA Letters patent sealed or granted (standard patent)